Ebtisam Ali Hassan Aljaizani
Biographic Data
| ID | 8429872 |
|---|---|
| NAME | Ebtisam Ali Hassan Aljaizani |
| GIVEN NAMES | Ebtisam Ali Hassan |
| FAMILY NAME | Aljaizani |
| SIGNATURE | ALJAIZANI E A H |
| AFFILIATIONS | Ministry of Health of the Russian Federation |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Ciprofloxacin
Background: Ciprofloxacin, a fluoroquinolone antibiotic patented in 1983 and FDA-approved in 1987, is widely used for bacterial infections. It treats urinary tract infections (UTIs), pneumonia, and more, including off-label uses like Crohn’s disease and cancer cell suppression. Aim: To provide an overview of ciprofloxacin’s uses, mechanism of action, pharmacokinetics, administration, and associated adverse effects. Methods: A comprehensive review…
Impact of Medication Therapy Management Services on Patient Outcomes
This extensive analysis investigates the influence of Medication Therapy Management (MTM) services on patient outcomes, specifically emphasizing medication adherence, health-related quality of life, healthcare usage, and cost savings. We performed a comprehensive review and meta-analysis of relevant literature over the last decade to assess the efficacy of MTM services. The study included research that encompassed a wide range of patient demograp…
No prominent works on this page.
Impact of Medication Therapy Management Services on Patient Outcomes
This extensive analysis investigates the influence of Medication Therapy Management (MTM) services on patient outcomes, specifically emphasizing medication adherence, health-related quality of life, healthcare usage, and cost savings. We performed a comprehensive review and meta-analysis of relevant literature over the last decade to assess the efficacy of MTM services. The study included research that encompassed a wide range of patient demograp…
Ciprofloxacin
Background: Ciprofloxacin, a fluoroquinolone antibiotic patented in 1983 and FDA-approved in 1987, is widely used for bacterial infections. It treats urinary tract infections (UTIs), pneumonia, and more, including off-label uses like Crohn’s disease and cancer cell suppression. Aim: To provide an overview of ciprofloxacin’s uses, mechanism of action, pharmacokinetics, administration, and associated adverse effects. Methods: A comprehensive review…
Medicine (2 works) · Adverse effect (1 work) · Antibiotics (1 work) · Antibiotics Pharmacokinetics and Efficacy (1 work) · Biochemistry (1 work) · Blood Pressure and Hypertension Studies (1 work) · Chemistry (1 work) · Ciprofloxacin (1 work) · Demographics (1 work) · Epilepsy research and treatment (1 work)